| Similar Articles |
|---|
 |
BusinessWeek
September 4, 2008
Pete Engardio |
Chinese Scientists Build Big Pharma Back Home In a reverse migration, U.S.-trained scientists are setting up biotech startups, contract-research companies, and university labs on the mainland.   |
Pharmaceutical Executive
September 1, 2008
Zhu Shen |
Unleash the Dragon Concerns over quality? It's not stopping Big Pharma outsourcing and venture capital. |
Pharmaceutical Executive
December 1, 2010
Zhu Shen |
China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda |
Chemistry World
December 2006
Derek Lowe |
Opinion: In the Pipeline A look at the story behind the growing investment by western companies in medicinal chemistry research in China. |
Chemistry World
October 28, 2014
Hepeng Jia |
China's science academy launches new reform drive The Chinese Academy of Sciences, the nation's largest research body, is to reshuffle its 100 plus research institutes and change the way it rewards scientists. |
The Motley Fool
August 13, 2007
Andrew R. Vaino |
Do You See What I WuXi? This Chinese biotech outsourcing firm recently went public and has lots of room to grow. |
BusinessWeek
November 19, 2009
Pete Engardio |
China's Reverse Brian Drain Beijing is making progress in its effort to lure back top Chinese scientists working overseas. |
Chemistry World
July 15, 2008
Hepeng Jia |
Testing Times for New Liver Drug AstraZeneca is set to start clinical trials of a liver cancer drug developed for Chinese patients. |
Chemistry World
November 20, 2007
Hepeng Jia |
China Leaps up Research League Table China has overtaken Japan and the UK to become the world's second largest producer of science and technology (S&T) papers. |
Bio-IT World
October 2006
Thomas G. Morr |
Eight Essential Elements for Commercial Success For life sciences companies both young and old, location is one of the critical success factors. With that in mind, here are eight essential considerations for life sciences executives when they are thinking of starting a business or opening a new location. |
Pharmaceutical Executive
November 1, 2012
Greg Lovas |
The Battle's on for HR Success in China Chinese start-ups have realized that they need to recruit highly skilled and globally oriented general managers from foreign multinationals when they reach a critical size. |
The Motley Fool
March 6, 2009
Brian Orelli |
For Drug Companies, R&D Is Spelled C-R-O It seems likely that more and more pharma companies will try to get more bang for their bucks by spending them on research and development done outside the company, outsourcing it to clinical research organizations. |
Bio-IT World
June 15, 2003
Bob Violino |
Mid-Atlantic/Southeast Region Maryland: Making a Federal Case for Biotechnology... Puerto Rico: Isle of Incentives... Virginia: Planting Needed Seed Capital... North Carolina: Triangulating Biotech Resources... Florida: Shining Resources on Small Biotech Sector |
Bio-IT World
June 15, 2003
Melissa Kruse |
Midwest/South Region Ohio: Outpacing U.S. in Bioscience Growth... Alabama: Sweet Home to Tech Tax Incentives... Kentucky: Investing Multimillions to Breed Bio Business... Minnesota: The 'Right Mix' of Talent and Funding... Tennessee: Pioneering Research Centers... Michigan: Teeming 'Life Sciences Corridor'... etc. |
The Motley Fool
August 1, 2008
Brian Orelli |
Recession Schmession, This Industry Is On Fire Contract research organizations do pre-clinical research and run clinical trials for drug developers on the cheap. With pharmaceutical companies cutting back on costs, CROs are in the perfect position to benefit. |
Chemistry World
October 11, 2007
Hepeng Jia |
China's Drug Industry Set to Take Off Producing cheap drugs for the developing world could allow Chinese pharmaceutical firms to capture a bigger share of the international market, industry experts suggest. |
BusinessWeek
December 13, 2004
Bruce Einhorn |
Go East, Big Pharma Drugmakers are expanding in China, but patents are still a worry. |
BusinessWeek
November 6, 2006
Bruce Einhorn |
A Dragon In R&D China's labs may soon rival its powerhouse factories - and multinationals are flocking in for tech innovation. |
Chemistry World
February 2008
Derek Lowe |
Column: In the Pipeline Does it matter whether or not a pharmaceutical company is run by a chemist? |
HBS Working Knowledge
January 22, 2007
Michael Roberts |
The Immigrant Technologist: Studying Technology Transfer with China Professor William Kerr discusses the phenomena of technology transfer and implications for U.S.-based businesses and policymakers. |
Bio-IT World
March 10, 2003
Mark D. Uehling |
Technology Overload Inundated with new IT tools and mountains of data, the pharmaceutical industry struggles to pull it all together. |
Pharmaceutical Executive
June 1, 2013 |
When Gurus Get It Wrong Despite their high status, management gurus aren't always on point when it comes to pharma, writes John Ansell. |
The Motley Fool
December 27, 2007
Brian Orelli |
Drugmaker Growth: The China Connection Just like other industries, the pharmaceutical industry has realized that China is a good place to find cheap labor. While reluctant to set up FDA-regulated manufacturing plants in China, other stages of drug development can be done there. |
The Motley Fool
July 27, 2011
Michael Olsen |
Rising Stars Buy: Icon Icon, the fourth-largest CRO, sits among the global elite and makes for a healthy investment. |
The Motley Fool
April 20, 2011
Brandon Glenn |
Growing CRO Demand Boosts Outlook for Kendle It's been rough going lately for Kendle. |
Bio-IT World
May 2006
Mark D. Uehling |
Bio-IT World CTMS Survey An online survey of the clinical trial management system market reveals some divergences between how the pharma/biotech folks and the contract research folks see the CTMS landscape. Are our respondents happy with the CTMS landscape? |
The Motley Fool
October 29, 2009
Robert Steyer |
Pharma Researchers Need a Cure As the industry changes, Pharmaceutical Product Development and Parexel International struggle. |
The Motley Fool
July 30, 2009
Robert Steyer |
Covance Advances Covance latest results produce more optimism than did some of its contract research peers. |
Chemistry World
January 2007
Sue Ferns |
Comment: Who's Looking After British Science? As the union representing public sector scientists in the UK, Prospect is calling for urgent action to stem the loss of key science research facilities and staff. |
The Motley Fool
July 22, 2009
Robert Steyer |
Canaries in the Drug Coal Mine Contract research organizations like Pharmaceutical Product Development and ICON reflect an ailing drug industry. |
Reactive Reports
Issue 57 |
Interview with Andrew Lemon With a background in Chemistry and a keen sense of business, this co-found of The Edge Software Consultancy helps global pharmaceutical companies increase the efficiency and productivity of their software tools. |
Chemistry World
April 10, 2008
Luisa Massarani |
Brazil Pins Economic Hopes on Science Brazil's future prosperity depends on training more young scientists. |
Chemistry World
July 24, 2008
Hepeng Jia |
Chemists join Olympic clean-up effort Chemists have played a vital role in improving Beijing's air quality for the Olympics, guiding the government's massive clean-up operation by highlighting and monitoring major pollution sources. |
The Motley Fool
November 30, 2007
Brian Orelli |
Clinical Trial Failures Don't Bother These Companies Contract research organizations, outsourcing companies hired by pharmaceutical and biotech companies to run pre-clinical tests and clinical trials for them, succeed even when drugs fail, and more work may be coming their way. |
The Motley Fool
April 24, 2009
Robert Steyer |
Nothing to CRO About The good times have stopped rolling for Contract research organizations, as they warn of unexpected contract cancellations and reduced demand for services. |
The Motley Fool
September 9, 2004
Charly Travers |
The Case for Drug Stocks The reports of the drug industry's death are greatly exaggerated. |
Chemistry World
September 7, 2011
Andrew Turley |
First Pfizer Spinout at Sandwich Green shoots of recovery are starting to sprout at the Pfizer site in Sandwich, UK, with the first spinout opening its doors. |
Chemistry World
May 2007 |
Comment: A Matter of Ethics Scientists should embrace a universal ethical code. |
Chemistry World
October 22, 2014
Rebecca Trager |
Free legal help for embattled US scientists A pro bono network that will provide legal protection for US scientists in government and academia has been launched by the Public Employees for Environmental Responsibility, an environmental group based in Washington, DC. |
Chemistry World
August 12, 2008 |
EU Plans to Share More Science Funds and Facilities The new 'Joint Programming' initiative aims to reduce the duplication of research efforts by scientists in EU member states through shared multinational funding pots that would be open to scientists from all participating countries. |
The Motley Fool
August 27, 2011
Michael Olsen |
Rising Star Buy: More Icon Icon shares might not appreciate tomorrow, and they might decline more before they go up. But here is a rare value: a secular growth story at a stellar valuation. |
Pharmaceutical Executive
June 1, 2011 |
Filling in the Bigger Picture Part II of The Avoca Group's 2011 CRO survey on clinical development outsourcing relationships. |
Bio-IT World
January 13, 2003
Mark D. Uehling |
Powerhouse CRO (Slowly) Goes Electronic Unhappy customers at Quintiles -- the world's largest CRO (contract research organization) -- are rare. It kept plugging away at the startup process, redesigning it from scratch. Now starting electronic trials takes no longer than paper ones. |
Salon.com
August 18, 2000
Arthur Allen |
Tainted alliances Are doctors shilling for drug companies? |
Bio-IT World
September 16, 2004
Paul King |
Growing Gains When it comes to information technology requirements, the biotech industry is unlike any other. A key enabler of efficient and effective growth is the adoption of IT strategies specific to each of four key stages. |
Entrepreneur
January 2008
Chris Penttila |
Can You Compete? Chinese manufacturers aren't just making your stuff - they're making their own, too. |
BusinessWeek
July 23, 2007
Engardio et al. |
Broken China Beijing can't clean up the environment, rein in stock speculation, or police its companies. Why the mainland's problems could keep it from becoming the next superpower |
Pharmaceutical Executive
April 1, 2009
David Zuckerman |
Make a Match Big Pharma is finally making a commitment to partner-based outsourcing. |
